Citation: Ks. Thomson et Cc. Sanders, THE EFFECTS OF INCREASING LEVELS OF QUINOLONE RESISTANCE ON IN-VITRO ACTIVITY OF 4 QUINOLONES, Journal of antimicrobial chemotherapy, 42(2), 1998, pp. 179-187
Citation: Es. Moland et al., CAN RESULTS OBTAINED WITH COMMERCIALLY AVAILABLE MICROSCAN MICRODILUTION PANELS SERVE AS AN INDICATOR OF BETA-LACTAMASE PRODUCTION AMONG ESCHERICHIA-COLI AND KLEBSIELLA ISOLATES WITH HIDDEN RESISTANCE TO EXPANDED-SPECTRUM CEPHALOSPORINS AND AZTREONAM, Journal of clinical microbiology, 36(9), 1998, pp. 2575-2579
Citation: Pd. Lister et al., CEFEPIME-AZTREONAM - A UNIQUE DOUBLE BETA-LACTAM COMBINATION FOR PSEUDOMONAS-AERUGINOSA, Antimicrobial agents and chemotherapy, 42(7), 1998, pp. 1610-1619
Authors:
PITOUT JDD
THOMSON KS
HANSON ND
EHRHARDT AF
MOLAND ES
SANDERS CC
Citation: Jdd. Pitout et al., BETA-LACTAMASES RESPONSIBLE FOR RESISTANCE TO EXPANDED-SPECTRUM CEPHALOSPORINS IN KLEBSIELLA-PNEUMONIAE, ESCHERICHIA-COLI, AND PROTEUS-MIRABILIS ISOLATES RECOVERED IN SOUTH-AFRICA, Antimicrobial agents and chemotherapy, 42(6), 1998, pp. 1350-1354
Authors:
PITOUT JDD
THOMSON KS
HANSON ND
EHRHARDT AF
COUDRON P
SANDERS CC
Citation: Jdd. Pitout et al., PLASMID-MEDIATED RESISTANCE TO EXPANDED-SPECTRUM CEPHALOSPORINS AMONGENTEROBACTER-AEROGENES STRAINS, Antimicrobial agents and chemotherapy, 42(3), 1998, pp. 596-600
Authors:
MEIER PA
DOOLEY DP
JORGENSEN JH
SANDERS CC
HUANG WM
PATTERSON JE
Citation: Pa. Meier et al., DEVELOPMENT OF QUINOLONE-RESISTANT CAMPYLOBACTER-FETUS BACTEREMIA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS, The Journal of infectious diseases, 177(4), 1998, pp. 951-954
Citation: We. Sanders et Cc. Sanders, ENTEROBACTER SPP - PATHOGENS POISED TO FLOURISH AT THE TURN-OF-THE-CENTURY, Clinical microbiology reviews, 10(2), 1997, pp. 220
Citation: We. Sanders et Cc. Sanders, ENTEROBACTER SPP - PATHOGENS POISED TO FLOURISH AT THE TURN-OF-THE-CENTURY, Clinical microbiology reviews, 10(2), 1997, pp. 220
Authors:
VERCAUTEREN E
DESCHEEMAEKER P
IEVEN M
SANDERS CC
GOOSSENS H
Citation: E. Vercauteren et al., COMPARISON OF SCREENING METHODS FOR DETECTION OF EXTENDED-SPECTRUM BETA-LACTAMASES AND THEIR PREVALENCE AMONG BLOOD ISOLATES OF ESCHERICHIA-COLI AND KLEBSIELLA SPP IN A BELGIAN TEACHING HOSPITAL, Journal of clinical microbiology, 35(9), 1997, pp. 2191-2197
Citation: Pe. Coudron et al., OCCURRENCE AND DETECTION OF EXTENDED-SPECTRUM BETA-LACTAMASES IN MEMBERS OF THE FAMILY ENTEROBACTERIACEAE AT A VETERANS MEDICAL-CENTER - SEEK AND YOU MAY FIND, Journal of clinical microbiology, 35(10), 1997, pp. 2593-2597
Citation: Pd. Lister et al., RATIONALE BEHIND HIGH-DOSE AMOXICILLIN THERAPY FOR ACUTE OTITIS-MEDIADUE TO PENICILLIN-NONSUSCEPTIBLE PNEUMOCOCCI - SUPPORT FROM IN-VITRO PHARMACODYNAMIC STUDIES, Antimicrobial agents and chemotherapy, 41(9), 1997, pp. 1926-1932
Authors:
SANDERS CC
BRADFORD PA
EHRHARDT AF
BUSH K
YOUNG KD
HENDERSON TA
SANDERS EW
Citation: Cc. Sanders et al., PENICILLIN-BINDING PROTEINS AND INDUCTION OF AMPC BETA-LACTAMASE, Antimicrobial agents and chemotherapy, 41(9), 1997, pp. 2013-2015
Citation: Pd. Lister et al., IMPORTANCE OF BETA-LACTAMASE INHIBITOR PHARMACOKINETICS IN THE PHARMACODYNAMICS OF INHIBITOR-DRUG COMBINATIONS - STUDIES WITH PIPERACILLIN-TAZOBACTAM AND PIPERACILLIN-SULBACTAM, Antimicrobial agents and chemotherapy, 41(4), 1997, pp. 721-727
Authors:
THOMSON KS
CHARTRAND SA
SANDERS CC
BLOCK SL
Citation: Ks. Thomson et al., TROVAFLOXACIN, A NEW FLUOROQUINOLONE WITH POTENT ACTIVITY AGAINST STREPTOCOCCUS-PNEUMONIAE, Antimicrobial agents and chemotherapy, 41(2), 1997, pp. 478-480
Citation: Af. Ehrhardt et Cc. Sanders, STRUCTURE-ACTIVITY STUDIES OF QUINOLONE-PENEMS IN GENETICALLY DEFINEDSTRAINS OF ESCHERICHIA-COLI, Antimicrobial agents and chemotherapy, 41(11), 1997, pp. 2570-2572
Authors:
PITOUT JDD
MOLAND ES
SANDERS CC
THOMSON KS
FITZSIMMONS SR
Citation: Jdd. Pitout et al., BETA-LACTAMASES AND DETECTION OF BETA-LACTAM RESISTANCE IN ENTEROBACTER SPP, Antimicrobial agents and chemotherapy, 41(1), 1997, pp. 35-39
Citation: Jdd. Pitout et al., ANTIMICROBIAL RESISTANCE WITH FOCUS ON BETA-LACTAM RESISTANCE IN GRAM-NEGATIVE BACILLI, The American journal of medicine, 103(1), 1997, pp. 51-59
Citation: Cc. Sanders, IN-VITRO ACTIVITY OF 4TH-GENERATION CEPHALOSPORINS AGAINST ENTEROBACTERIACEAE PRODUCING EXTENDED-SPECTRUM BETA-LACTAMASES, Journal of chemotherapy, 8, 1996, pp. 57-62
Citation: We. Sanders et Cc. Sanders, PIPERACILLIN TAZOBACTAM - A CRITICAL-REVIEW OF THE EVOLVING CLINICAL LITERATURE, Clinical infectious diseases, 22(1), 1996, pp. 107-123
Authors:
SANDERS CC
BARRY AL
WASHINGTON JA
SHUBERT C
MOLAND ES
TRACZEWSKI MM
KNAPP C
MULDER R
Citation: Cc. Sanders et al., DETECTION OF EXTENDED-SPECTRUM-BETA-LACTAMASE-PRODUCING MEMBERS OF THE FAMILY ENTEROBACTERIACEAE WITH THE VITEK ESBL TEST, Journal of clinical microbiology, 34(12), 1996, pp. 2997-3001
Authors:
EHRHARDT AF
SANDERS CC
ROMERO JR
LESER JS
Citation: Af. Ehrhardt et al., SEQUENCING AND ANALYSIS OF 4 NEW ENTEROBACTER AMPD ALLELES, Antimicrobial agents and chemotherapy, 40(8), 1996, pp. 1953-1956
Citation: M. Alexov et al., EFFICACY OF AMPICILLIN-SULBACTAM IS NOT DEPENDENT UPON MAINTENANCE OFA CRITICAL RATIO BETWEEN COMPONENTS - SULBACTAM PHARMACOKINETICS IN PHARMACODYNAMIC INTERACTIONS, Antimicrobial agents and chemotherapy, 40(11), 1996, pp. 2468-2477
Citation: Cc. Sanders et Es. Moland, CEFEPIME - THE LAST GENERATION OR THE FIRST ENHANCED-POTENCY BROAD-SPECTRUM CEPHALOSPORIN, Clinical drug investigation, 10(6), 1995, pp. 344-354
Citation: Cc. Sanders et al., FLUOROQUINOLONE RESISTANCE IN STAPHYLOCOCCI - NEW CHALLENGES, European journal of clinical microbiology & infectious diseases, 14, 1995, pp. 6-11